Syndax Pharmaceuticals Inc (SNDX)
20.28
+0.17
(+0.85%)
USD |
NASDAQ |
May 24, 16:00
20.29
+0.01
(+0.05%)
After-Hours: 20:00
Syndax Pharmaceuticals Cash and Short Term Investments (Quarterly): 443.16M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 443.16M |
| December 31, 2023 | 577.58M |
| September 30, 2023 | 373.82M |
| June 30, 2023 | 406.02M |
| March 31, 2023 | 438.20M |
| December 31, 2022 | 484.40M |
| September 30, 2022 | 350.71M |
| June 30, 2022 | 376.68M |
| March 31, 2022 | 410.91M |
| December 31, 2021 | 446.83M |
| September 30, 2021 | 229.71M |
| June 30, 2021 | 253.13M |
| March 31, 2021 | 271.34M |
| December 31, 2020 | 293.06M |
| September 30, 2020 | 170.16M |
| June 30, 2020 | 186.75M |
| March 31, 2020 | 99.00M |
| December 31, 2019 | 59.78M |
| September 30, 2019 | 72.24M |
| June 30, 2019 | 80.52M |
| Date | Value |
|---|---|
| March 31, 2019 | 92.74M |
| December 31, 2018 | 80.91M |
| September 30, 2018 | 89.60M |
| June 30, 2018 | 98.38M |
| March 31, 2018 | 113.22M |
| December 31, 2017 | 129.97M |
| September 30, 2017 | 120.59M |
| June 30, 2017 | 129.96M |
| March 31, 2017 | 92.78M |
| December 31, 2016 | 105.33M |
| September 30, 2016 | 115.57M |
| June 30, 2016 | 125.46M |
| March 31, 2016 | 133.67M |
| December 31, 2015 | 86.49M |
| September 30, 2015 | 100.46M |
| December 31, 2014 | 12.21M |
| September 30, 2014 | 11.69M |
| June 30, 2014 | 5.01M |
| March 31, 2014 | 9.497M |
| December 31, 2013 | 14.26M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
59.78M
Minimum
Dec 2019
577.58M
Maximum
Dec 2023
301.20M
Average
321.89M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Geron Corp | 443.05M |
| Verastem Inc | 110.12M |
| Karyopharm Therapeutics Inc | 148.58M |
| Crinetics Pharmaceuticals Inc | 900.96M |
| Arvinas Inc | 1.169B |